Prati
Pantelis Sarafidis
Pantelis Sarafidis
Potvrđena adresa e-pošte na auth.gr
Naslov
Citirano
Citirano
Godina
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by …
G Mancia, R Kreutz, M Brunström, M Burnier, G Grassi, A Januszewicz, ...
Journal of hypertension 41 (12), 1874-2071, 2023
18852023
Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary …
GL Bakris, PA Sarafidis, MR Weir, B Dahlöf, B Pitt, K Jamerson, ...
The Lancet 375 (9721), 1173-1181, 2010
776*2010
Resistant hypertension: an overview of evaluation and treatment
PA Sarafidis, GL Bakris
Journal of the American College of Cardiology 52 (22), 1749-1757, 2008
5732008
The systemic nature of CKD
C Zoccali, R Vanholder, ZA Massy, A Ortiz, P Sarafidis, FW Dekker, ...
Nature Reviews Nephrology 13 (6), 344-358, 2017
4472017
Hypertension awareness, treatment, and control in chronic kidney disease
PA Sarafidis, S Li, SC Chen, AJ Collins, WW Brown, MJ Klag, GL Bakris
The American journal of medicine 121 (4), 332-340, 2008
3792008
Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome
G Bakris, M Molitch, A Hewkin, M Kipnes, P Sarafidis, K Fakouhi, ...
Diabetes Care 29 (12), 2592-2597, 2006
3692006
Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications
PA Sarafidis, LM Ruilope
American journal of nephrology 26 (3), 232-244, 2006
3382006
The metabolic syndrome: a glance at its history
PA Sarafidis, PM Nilsson
Journal of hypertension 24 (4), 621-626, 2006
3302006
Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association–European …
PA Sarafidis, A Persu, R Agarwal, M Burnier, P de Leeuw, CJ Ferro, ...
Nephrology dialysis transplantation 32 (4), 620-640, 2017
3142017
Antihypertensive therapy in the presence of proteinuria
PA Sarafidis, N Khosla, GL Bakris
American Journal of Kidney Diseases 49 (1), 12-26, 2007
2932007
Protection of the kidney by thiazolidinediones: an assessment from bench to bedside
PA Sarafidis, GL Bakris
Kidney international 70 (7), 1223-1233, 2006
2832006
Effect of thiazolidinediones on albuminuria and proteinuria in diabetes: a meta-analysis
PA Sarafidis, PC Stafylas, PI Georgianos, AN Saratzis, AN Lasaridis
American Journal of Kidney Diseases 55 (5), 835-847, 2010
2502010
Resistant hypertension—its identification and epidemiology
PA Sarafidis, P Georgianos, GL Bakris
Nature Reviews Nephrology 9 (1), 51-58, 2013
2482013
Lipid management in patients with chronic kidney disease
CJ Ferro, PB Mark, M Kanbay, P Sarafidis, GH Heine, P Rossignol, ...
Nature Reviews Nephrology 14 (12), 727-749, 2018
2392018
Prevalence and factors associated with hyperkalemia in predialysis patients followed in a low-clearance clinic
PA Sarafidis, R Blacklock, E Wood, A Rumjon, S Simmonds, ...
Clinical Journal of the American Society of Nephrology 7 (8), 1234-1241, 2012
2222012
Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
JE Flythe, TI Chang, MP Gallagher, E Lindley, M Madero, PA Sarafidis, ...
Kidney international 97 (5), 861-876, 2020
2162020
SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by …
P Sarafidis, CJ Ferro, E Morales, A Ortiz, J Malyszko, R Hojs, K Khazim, ...
Nephrology Dialysis Transplantation 34 (2), 208-230, 2019
2162019
The agreement between auscultation and lung ultrasound in hemodialysis patients: the LUST study
C Torino, L Gargani, R Sicari, K Letachowicz, R Ekart, D Fliser, A Covic, ...
Clinical Journal of the American Society of Nephrology 11 (11), 2005-2011, 2016
2062016
Insulin and endothelin: an interplay contributing to hypertension development?
PA Sarafidis, GL Bakris
The Journal of Clinical Endocrinology & Metabolism 92 (2), 379-385, 2007
1822007
Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes
PA Sarafidis, AN Lasaridis, PM Nilsson, MI Pikilidou, PC Stafilas, ...
Journal of human hypertension 21 (9), 709-716, 2007
1732007
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20